Chemomab Therapeutics Ltd. Capital Expenditures
Chemomab Therapeutics Ltd. (CMMB) reported Capital Expenditures of $3.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-23
- Chemomab Therapeutics Ltd. payments to acquire property, plant, and equipment for the quarter ending 2023-06-30 was $2.00K, a 81.82% decline year-over-year.
- Chemomab Therapeutics Ltd. payments to acquire property, plant, and equipment for the quarter ending 2023-03-31 was $1.00K, a 92.86% decline year-over-year.
- Chemomab Therapeutics Ltd. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $1.00K, a 99.25% decline year-over-year.
- Chemomab Therapeutics Ltd. payments to acquire property, plant, and equipment for the quarter ending 2022-09-30 was $42.00K.
- Chemomab Therapeutics Ltd. payments to acquire property, plant, and equipment for fiscal 2020 was $38.00K, a 60.00% decline from fiscal 2019.
- Chemomab Therapeutics Ltd. payments to acquire property, plant, and equipment for fiscal 2019 was $95.00K, a 55.40% decline from fiscal 2018.
- Chemomab Therapeutics Ltd. payments to acquire property, plant, and equipment for fiscal 2018 was $213.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $3.00K 20-F · filed 2026-03-23 | |||||||
| 2024-12-31 | $0.00 20-F · filed 2026-03-23 | |||||||
| 2024-06-30 | $0.00 6-K · filed 2024-08-21 | |||||||
| 2023-12-31 | $3.00K 20-F · filed 2026-03-23 | |||||||
| 2023-06-30 | $2.00K derived: 6-K 6 month − 10-Q 3 month · filed 2024-08-21 | $3.00K 6-K · filed 2024-08-21 | $4.00K derived: sum of 3 quarters · filed 2025-04-04 | $46.00K derived: sum of 4 quarters · filed 2025-04-04 | ||||
| 2023-03-31 | $1.00K 10-Q · filed 2023-05-11 | $2.00K derived: sum of 2 quarters · filed 2025-04-04 | $44.00K derived: sum of 3 quarters · filed 2025-04-04 | $55.00K derived: sum of 4 quarters · filed 2025-04-04 | ||||
| 2022-12-31 | $1.00K derived: 20-F 12 month − 10-Q 9 month · filed 2025-04-04 | $43.00K derived: sum of 2 quarters · filed 2025-04-04 | $54.00K derived: sum of 3 quarters · filed 2025-04-04 | $68.00K 20-F · filed 2025-04-04 | ||||
| 2022-09-30 | $42.00K derived: 10-Q 9 month − 6-K 6 month · filed 2022-11-10 | $53.00K derived: sum of 2 quarters · filed 2023-08-14 | $67.00K 10-Q · filed 2022-11-10 | $201.00K derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2022-06-30 | $11.00K derived: 6-K 6 month − 10-Q 3 month · filed 2023-08-14 | $25.00K 6-K · filed 2023-08-14 | $159.00K derived: sum of 3 quarters · filed 2024-03-28 | $159.00K derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2022-03-31 | $14.00K 10-Q · filed 2023-05-11 | $148.00K derived: sum of 2 quarters · filed 2024-03-28 | $148.00K derived: sum of 3 quarters · filed 2024-03-28 | $250.00K derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2021-12-31 | $134.00K derived: 20-F 12 month − 10-Q 9 month · filed 2024-03-28 | $134.00K derived: sum of 2 quarters · filed 2024-03-28 | $236.00K derived: sum of 3 quarters · filed 2024-03-28 | $239.00K 20-F · filed 2024-03-28 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $102.00K derived: sum of 2 quarters · filed 2022-11-10 | $105.00K 10-Q · filed 2022-11-10 | $106.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $105.00K 10-Q · filed 2022-08-12 | $106.00K derived: sum of 3 quarters · filed 2022-08-12 | $126.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-12 | $4.00K derived: sum of 2 quarters · filed 2022-05-12 | $24.00K derived: sum of 3 quarters · filed 2022-05-12 | $31.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $21.00K derived: sum of 2 quarters · filed 2022-03-30 | $28.00K derived: sum of 3 quarters · filed 2022-03-30 | $38.00K 10-K · filed 2022-03-30 | $34.00K 10-K · filed 2021-03-09 | |||
| 2020-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $27.00K derived: sum of 2 quarters · filed 2021-11-12 | $37.00K 10-Q · filed 2021-11-12 | $34.00K 10-Q · filed 2020-11-16 | -$214.00K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $17.00K 10-Q · filed 2021-08-13 | $34.00K 10-Q · filed 2020-08-14 | -$234.00K derived: sum of 3 quarters · filed 2021-08-13 | $21.00K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $10.00K 10-Q · filed 2021-05-13 | $34.00K 10-Q · filed 2020-05-07 | -$241.00K derived: sum of 2 quarters · filed 2021-05-13 | $14.00K derived: sum of 3 quarters · filed 2021-05-13 | $30.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $4.00K derived: sum of 2 quarters · filed 2021-03-09 | $20.00K derived: sum of 3 quarters · filed 2021-03-09 | $95.00K 10-K · filed 2021-03-09 | ||||
| 2019-09-30 | $255.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $271.00K derived: sum of 2 quarters · filed 2020-11-16 | $346.00K 10-Q · filed 2020-11-16 | |||||
| 2019-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $91.00K 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | $75.00K 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | $213.00K 10-K · filed 2020-03-17 |